Literature DB >> 15805581

Serum levels of leptin, insulin, and lipids in relation to breast cancer in china.

Cunzhi Han1, Hong-Tao Zhang, Lili Du, Xiuying Liu, Jiexian Jing, Xianwen Zhao, Xuan Yang, Baoguo Tian.   

Abstract

Epidemiological studies have found obesity to be a risk factor for women's breast cancer. The present study was to investigate whether there is a relationship between serum levels of leptin, insulin, and lipids and breast cancer incidence, in order to find experimental evidence that would be helpful in the diagnosis and prevention of breast cancer. Blood samples were collected from 130 patients with mammary disease and 103 healthy control subjects. Serum leptin, insulin, and lipids were determined by radioimmunoassay (RIA), enzyme-linked immunosorbent assays (ELISA), and Biochemistry Auto-analyzer, respectively. The data analysis was performed by use of the SPSS10.0 computer software. We found that the serum levels of leptin, insulin, and triglyceride (TG) were clearly higher in patients with breast cancer than in patients with benign breast disease and healthy controls, while serum HDL-C levels were lower in breast cancer patients (p < 0.03). Moreover, serum leptin levels were significantly correlated with BMI (body mass index) among three groups, whereas serum insulin levels were unrelated to BMI among three groups. Furthermore, the serum levels of leptin and insulin were not associated with menopausal status in patients with mammary disease (p > 0.05); however, the serum levels of F-Chol, T-Chol, TG, LDL-C, and APOB were significant higher in postmenopausal cases than those in premenopausal cases (p < 0.025). Interestingly, logistic regression analysis showed that subjects with elevated serum levels of leptin, insulin, TG, APOA1, and reduced level of serum HDL-C displayed increased risk of developing breast cancer than those with the normal levels, respectively. In conclusion, the present study suggested that aberrant serum levels of leptin, insulin, and lipids might play an important role in carcinogenesis of breast cancer. The elevated serum levels of leptin, insulin, TG, APOA1, and reduced level of serum HDL-C may be correlated with increased risk of breast cancer, suggesting that one way of preventing breast cancer would be carried out by controlling the intake of food.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15805581     DOI: 10.1385/ENDO:26:1:019

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

1.  Prostate cancer risk and serum levels of insulin and leptin: a population-based study.

Authors:  A W Hsing; S Chua; Y T Gao; E Gentzschein; L Chang; J Deng; F Z Stanczyk
Journal:  J Natl Cancer Inst       Date:  2001-05-16       Impact factor: 13.506

2.  Serum leptin concentration and insulin sensitivity in men with abdominal obesity.

Authors:  G Johannsson; C Karlsson; L Lönn; P Mårin; P Björntorp; L Sjöström; B Carlsson; L M Carlsson; B A Bengtsson
Journal:  Obes Res       Date:  1998-11

3.  Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls.

Authors:  C S Mantzoros; K Bolhke; S Moschos; D W Cramer
Journal:  Int J Cancer       Date:  1999-02-09       Impact factor: 7.396

4.  Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women.

Authors:  H Larsson; S Elmståhl; B Ahrén
Journal:  Diabetes       Date:  1996-11       Impact factor: 9.461

Review 5.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

6.  Breast cancer size in postmenopausal women is correlated with body mass index and androgen serum levels.

Authors:  E Asseryanis; E Ruecklinger; M Hellan; E Kubista; C F Singer
Journal:  Gynecol Endocrinol       Date:  2004-01       Impact factor: 2.260

7.  Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women.

Authors:  Kaoru Hirose; Tatsuya Toyama; Hiroji Iwata; Toshiro Takezaki; Nobuyuki Hamajima; Kazuo Tajima
Journal:  Asian Pac J Cancer Prev       Date:  2003 Jul-Sep

8.  Leptin expression in colorectal and breast cancer patients.

Authors:  L Tessitore; B Vizio; O Jenkins; I De Stefano; C Ritossa; J M Argiles; C Benedetto; A Mussa
Journal:  Int J Mol Med       Date:  2000-04       Impact factor: 4.101

9.  Plasma insulin-like growth factor I and its binding proteins 1 and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen.

Authors:  E I Lahti; M Knip; T J Laatikainen
Journal:  Cancer       Date:  1994-07-15       Impact factor: 6.860

10.  Leptin induces cell migration and the expression of growth factors in human prostate cancer cells.

Authors:  Krista A Frankenberry; Ponnandai Somasundar; David W McFadden; Linda C Vona-Davis
Journal:  Am J Surg       Date:  2004-11       Impact factor: 2.565

View more
  55 in total

Review 1.  The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Authors:  Michael E Grossmann; Margot P Cleary
Journal:  Biochimie       Date:  2012-06-20       Impact factor: 4.079

Review 2.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.

Authors:  Shanchun Guo; Mingli Liu; Guangdi Wang; Marta Torroella-Kouri; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2012-01-24

3.  Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications.

Authors:  Antonio Macciò; Clelia Madeddu; Giulia Gramignano; Carlo Mulas; Carlo Floris; Daniela Massa; Giorgio Astara; Paola Chessa; Giovanni Mantovani
Journal:  J Mol Med (Berl)       Date:  2010-03-26       Impact factor: 4.599

4.  Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors.

Authors:  Melinda L Irwin; Anne McTiernan; Leslie Bernstein; Frank D Gilliland; Richard Baumgartner; Kathy Baumgartner; Rachel Ballard-Barbash
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-12       Impact factor: 4.254

5.  A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.

Authors:  Geoffrey C Kabat; Mimi Kim; Rowan T Chlebowski; Janu Khandekar; Marcia G Ko; Anne McTiernan; Marian L Neuhouser; Donna R Parker; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Thomas E Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

6.  Effects of a walking intervention using mobile technology and interactive voice response on serum adipokines among postmenopausal women at increased breast cancer risk.

Authors:  Adana A M Llanos; Jessica L Krok; Juan Peng; Michael L Pennell; Mara Z Vitolins; Cecilia R Degraffinreid; Electra D Paskett
Journal:  Horm Cancer       Date:  2014-01-17       Impact factor: 3.869

7.  Association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors.

Authors:  Sharon Wayne; Marian L Neuhouser; Cornelia M Ulrich; Carol Koprowski; Charles Wiggins; Kathy B Baumgartner; Leslie Bernstein; Richard N Baumgartner; Frank Gilliland; Anne McTiernan; Rachel Ballard-Barbash
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10-28       Impact factor: 4.254

8.  Circulating levels of leptin, adiposity and breast cancer risk.

Authors:  M-H Wu; Y-C Chou; W-Y Chou; G-C Hsu; C-H Chu; C-P Yu; J-C Yu; C-A Sun
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

9.  Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study.

Authors:  Michael N Okobia; Clareann H Bunker; Seymour J Garte; Joseph M Zmuda; Emmanuel R Ezeome; Stanley N Anyanwu; Emmanuel E Uche; Lewis H Kuller; Robert E Ferrell; Emanuela Taioli
Journal:  BMC Cancer       Date:  2008-11-18       Impact factor: 4.430

10.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.